Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase

Zeitschrift fur Kardiologie

Volumn 93, Issue 5, 2004, Pages 407-412

  Meyners, W ^a   Peters, S ^b   Trummel M ^b   Koehler, B ^b  

^a St Marien Krankenhaus Siegen gem GmbH   (Germany)

^b Klinikum Dorothea Christiane Erxleben Quedlinburg gGmbH   (Germany)

Author keywords

Alteplase; Glycoprotein IIb IIIa inhibitor; Intracoronary thrombolysis; Myocardial infarction; Percutaneous coronary intervention; Tirofiban

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CAPTOPRIL; CLOPIDOGREL; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIB; HEPARIN; TIROFIBAN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY RECANALIZATION; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECOVERY OF FUNCTION; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE; TREATMENT OUTCOME; TYROSINE;

EID: 2942612645     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0073-5     Document Type: Article

References (11)

1. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E, for the TACTICS-Thrombolysis in Myocardial Infarction 18 Investigators (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344:1879-1887
2. Eick B, Haude M, Altmann C, Liu F, Caspari G, Leischik R, Erbel R (1997) Behandlung eines großen intrakoronaren Thrombus mit Urokinase und einem chimären monoklonalen Thrombocytenaggregationshemmer. Dtsch Med Wschr 122:709-715
3. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H (2003) Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 107:2115-2119
4. Leopold JA, Loscalzo J (1995) Platelet activation by fibrinolytic agents: a potential mechanism for resistance to thrombolysis and reocclusion after successful thrombolysis. Coron Artery Dis 6:923-929
5. Peters S, Trümmel M, Brattström A, Meyners W (2002) Pilot study for the use of dose-reduced alteplase and the glycoprotein IIb/IIIa inhibitor tirofiban in acute myocardial infarction. Z Kardiol 91:233-237
6. Quinn EG, Fergusson DJG (1998) Coronary embolism following aortic and mitral valve replacement: successful management with abciximab and urokinase. Catheter Cardiovasc Interv 43:457-459
7. Rashdan I, Schechter E (2000) Safety and efficacy of abciximab use in conjunction with intracoronary urokinase in patients requiring angioplasty. Catheter Cardiovasc Interv 49:113-116
8. Rentrop KP, Blanke H, Karsch KR, Wiegand V, Kostering H, Oster H, Leitz K (1979) Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 2:354-363
9. The Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis (RESTORE) Investigators (1997) Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96:1445-1453
10. Tiefenbrunn AJ (1996) Intracoronary recombinant tissue-type plasminogen activator (rt-PA). Coron Artery Dis 7:637-640
11. Yaryura RA, Zaqqa M, Ferguson JJ (1998) Complications associated with combined use of abciximab and an intracoronary thrombolytic agent (urokinase or tissue-type plasminogen activator). Am J Cardiol 82:518-519